Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors

• Status: Completed
• Trial end date: 2019-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether psilocybin-assisted group psychotherapy is a safe and feasible treatment for demoralization in long-term AIDS survivors (LTAS).

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Joshua Woolley
• Collaborators: Heffter Research Institute; River Styx Foundation; Stupski Foundation; Usona Institute
• Treatments: N,N-Dimethyltryptamine; Psilocybin; Psilocybine

Criteria

Inclusion Criterion:

• Older individuals who are long-term AIDS survivors and suffer from moderate-to-severe demoralization.

Exclusion Criteria:

• A physical, neurological or cognitive condition that makes participating in the study unsafe or unfeasible.

• Regular psychotropic medication use.

• Personal or family history of serious mental illness.

• Severe depression requiring immediate standard-of-care treatment.

• Exclusion by the clinical judgment of the study investigators.